Abstract
By means of fluorescent microscopy, long-chain fatty acid derivatives, myristoylcarnitine and palmitoylcarnitine, were shown to exert the most toxic effect on rat ventricular cardiomyocytes. The addition of 20–50 μM acylcarnitines increased calcium concentration in cytoplasm ([Ca2+]i) and caused cell death after a lag-period of 4–8 min. This effect was independent of extracellular calcium level and Ca2+ inhibitors of L-type channels. Free myristic and palmitic acids at concentrations of 300–500 μM had little effect on [Ca2+]i within 30 min. We suggest that the toxic effect is due to the activation of calcium channels of sarcoplasmic reticulum by acylcarnitines and/or arising acyl-CoA. Mitochondria play a role of calcium-buffer system under these conditions. The calcium capacity of the buffer determines the duration of the lag-period. Phosphate increases the calcium capacity of mitochondria and the lag-period. In the presence of rotenone and oligomycin, the elevation of [Ca2+]i after the addition of acylcarnitines occurs without the lag-period. The exhaustion of the mitochondrial calcium-buffer capacity or significant depolarization of mitochondria leads to a rapid release of calcium from mitochondria and cell death. Thus, the activation of reticular calcium channels is the main reason of the toxicity of myristoylcarnitine and palmitoylcarnitine.
Similar content being viewed by others
Abbreviations
- FA:
-
fatty acids
- MPP:
-
mitochondrial permeable pore
- MC:
-
myristoylcarnitine
- PC:
-
palmitoylcarnitine
- RyR:
-
ryanodine channels
- IP3R:
-
IP3-sensitive channels
- SR:
-
sarcoplasmic reticulum
- SERCA:
-
sarcoplasmic/endoplasmic reticulum Ca2+-ATPase
- PMCA:
-
plasma membrane Ca2+-ATPase
References
B. Desvregne, L. Michalik, and W. Wahli, Mol. Endocrinol. 18(6), 1321 (2004).
J. M. McGavock, R. G. Victor, R. H. Unger, and L. S. Szczepaniak, Ann. Inter. Med. 144, 517 (2006).
A. M. Katz, J. Mol. Cell. Cardiol. 14, 627 (1982).
P. B. Corrs, R. W. Gross, and B. E. Sobel, Circ. Res. 55, 135 (1984).
A. J. Liedtke, J. Mol. Cell. Cardiol. 20, 65 (1988).
J. N. Weiss, P. Korge, H. M. Honda, and P. Ping, Circ. Res. 93(4), 292 (2003).
J. W. Phillis, F. G. Diaz, M. H. O’Regan, and J. G. Pilitsis, Brain Res. 957(1), 12 (2002).
L. Wojtczak, J. Bioenerg. 8(6), 293 (1976).
L. Wojtczak, M. R. Wieckowski, and P. Schunfeld, Arch. Biochem. Biophys. 357(1), 76 (1998).
P. Bernardi, D. Penzo, and L. Wojtczak, Vitam. Horm. 65, 97 (2002).
L. C. Trost and J. J. Lemasters, J. Pharmacol. Exp. Ther. 278, 1000 (1996).
L. C. Trost and J. J. Lemasters, Toxicol. Appl. Pharmacol. 147(2), 431 (1997).
D. Penzo, C. Tagliapietra, R. Colonna, et al., Biochim. Biophys. Acta 1555(1–3), 160 (2002).
V. Petronilli, D. Penzo, L. Scorrano, et al., J. Biol. Chem. 276(15), 12030 (2001).
E. V. Grishina, V. A. Kasymov, M. N. Nenov, et al., in Proceedings of International Conference on Reception and Intracellular Signalization, 2007, pp. 215–218.
A.V. Berezhnov, E. I. Fedotova, M. N. Nenov, et al., in Proceedings of International Conference on Reception and Intracellular Signalization, 2007, pp. 9–12.
M. Spedding and A. K. Mir, Br. J. Pharmacol. 92(2), 457 (1987).
J. Wu and P. B. Corr, Am. J. Physiol. 263, 410 (1992).
T. Netticadan, L. Yu, N. S. Dhalla, and V. Panagia, J. Mol. Cell. Cardiol. 31(7), 1357 (1999).
R. Fulceri, A. Nori, A. Gamberucci, et al., Cell Calcium 15(2), 109 (1994).
E. Dumonteil, H. Barr, and G. Meissner, J. Physiol. 479(1), 29 (1994).
R. el-Hayek, C. Valdivia, H. H. Valdivia, et al., Biophys. J. 65(2), 779 (1993).
K. A. Yamada, E. M. Kanter, and A. Newatia, J. Cardiovasc. Pharmacol. 36(1), 14 (2001).
R. Fulceri, A. Gamberucci, G. Bellomo, et al., Biochem. J. 295(3), 663 (1993).
R. J. Adams, D. W. Cohen, S. Gupte, et al., J. Biol. Chem. 254(24), 12404 (1979).
A. E. Alekseev, A. Jovanovic, J. R. Lopez, and A. Terzic, J. Mol. Cell. Cardiol. 28, 1193 (1996).
G. Meissner, Ann. Rev. Physiol. 56, 485 (1994).
M. R. Duchen, Diabetes 53, 96 (2004).
T. E. Gunter, L. Buntinas, G. Sparagna, et al., Call Calcium 28(5–6), 285 (2000).
M. Fill and J. A. Capello, Physiol. Rev. 82(4), 893 (2002).
R. Rizzuto, P. Bernardi, and T. Pozzan, J. Physiol. 529, 37 (2000).
V. Lukyanenko, A. Ziman, A. Lukyanenko, et al., J. Physiol. 583(1), 251 (2007).
D. R. Trollinger, W. E. Cascio, and J. J. Lemasters, Biophys. J. 79(1), 39 (2000).
K. C. Reed and F. L. Bygrave, Biochem J. 140(2), 143 (1974).
D. G. Nicholls and S. Chalmers, J. Bioenerg. Biomembr. 36(4), 277 (2004).
A. M. Surin, E. P. Bol’shakov, M. M. Mikhailova, et al., in Proceedings of International Conference on Reception and Intracellular Signalization, 2007, pp. 103–105.
S. Chalmers and D. G. Nicholls, J. Biol. Chem. 278, 19062 (2003).
L. Wojtczak, J. Bioenerg. Biomembr. 8(6), 293 (1976).
M. R. Wieckowski and L. Wojtczak, FEBS Lett. 423(3), 339 (1998).
G. D. Mironova, E. Gritsenko, O. Gateau-Roesch, et al., J. Bioenerg. Biomembr. 36(2), 171 (2004).
J. Fauconnier, D. C. Andersson, S. J. Zhang, et al., Diabetes 56(4), 1136 (2007).
J. C. Lai and A. J. Cooper, Neurochem. Res. 16(7), 795 (1991).
A. Kawaguchi and K. Bloch, J. Biol. Chem. 251(5), 1406 (1976).
S. V. Pande and M. C. Blanchaer, J. Biol. Chem. 246(2), 402 (1971).
S. Alexon, J. Nedergaard, and B. Cannon, Comp. Biochem. Physiol. B 83(1), 191 (1986).
R. Fulceri, R. Giunti, J. Knudsen, et al., Biochem. Biophys. Res. Commun. 264(2), 409 (1999).
R. Fulceri, J. Knudsen, R. Giunti, et al., Biochem. J. 325(2), 423 (1997).
Author information
Authors and Affiliations
Additional information
Original Russian Text © A.V. Berezhnov, E.I. Fedotova, M.N. Nenov, Yu.M. Kokoz, V.P. Zinchenko, V.V. Dynnik, 2008, published in Biofizika, 2008, Vol. 53, No. 6, pp. 1025–1032.
Rights and permissions
About this article
Cite this article
Berezhnov, A.V., Fedotova, E.I., Nenov, M.N. et al. Destabilization of the cytosolic calcium level and the death of cardiomyocytes in the presence of derivatives of long-chain fatty acids. BIOPHYSICS 53, 564–570 (2008). https://doi.org/10.1134/S0006350908060183
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006350908060183